These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6421562)

  • 1. [Prolonged coma caused by diazepam sedation in ventilated patients. Diagnostic and therapeutic use of the benzodiazepine antagonist Ro 15-1788].
    Rapold HJ; Follath F; Scollo-Lavizzari G; Kehl O; Ritz R
    Dtsch Med Wochenschr; 1984 Mar; 109(9):340-4. PubMed ID: 6421562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine antagonist Ro 15-1788 in self-poisoning. Diagnostic and therapeutic use.
    Hofer P; Scollo-Lavizzari G
    Arch Intern Med; 1985 Apr; 145(4):663-4. PubMed ID: 2859006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of the benzodiazepine antagonist flumazenil (Ro 15-1788) based on the EEG of mechanically ventilated intensive care patients].
    Kulka PJ; Lauven PM; Schwilden H; Rommelsheim K
    Anaesthesist; 1989 Aug; 38(8):424-30. PubMed ID: 2506776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific therapy of acute benzodiazepine poisoning using flumazenil (Ro 15-1788)].
    Hruby K; Prischl F; Smetana R; Pernecker M; Donner A; Scholtz I; Grimm G
    Wien Med Wochenschr; 1987 May; 137(9):179-83. PubMed ID: 2885978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of central benzodiazepine effects by flumazenil after conscious sedation produced by intravenous diazepam. The Flumazenil in Intravenous Conscious Sedation with Diazepam Multicenter Study Group I.
    Clin Ther; 1992; 14(6):895-909. PubMed ID: 1286497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of central benzodiazepine effects by flumazenil after intravenous conscious sedation with diazepam and opioids: report of a double-blind multicenter study. The Flumazenil in Intravenous Conscious Sedation with Diazepam Multicenter Study Group II.
    Clin Ther; 1992; 14(6):910-23. PubMed ID: 1286498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788).
    Lancet; 1985 Jun; 1(8441):1324-5. PubMed ID: 2860506
    [No Abstract]   [Full Text] [Related]  

  • 8. Flumazenil reversal of conscious sedation induced with intravenous fentanyl and diazepam.
    Finder RL; Moore PA; Close JM
    Anesth Prog; 1995; 42(1):11-6. PubMed ID: 8934956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First clinical investigation of the benzodiazepine antagonist Ro 15-1788 in comatose patients.
    Scollo-Lavizzari G
    Eur Neurol; 1983; 22(1):7-11. PubMed ID: 6132818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of midazolam and diazepam for sedation following aorto-coronary bypass surgery.
    Verwaest C; Demeyere R; Ferdinande P; Schetz M; Van Damme K; Lauwers P
    Acta Anaesthesiol Belg; 1987; 38(3 Suppl 1):9-16. PubMed ID: 3501221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnostic value and influence on EEG of Anexate (Flumazenil, Ro 15-1788) in benzodiazepine-intoxication. A case report.
    Gijsenbergh FP; Pillen EJ; Delooz HH
    Acta Anaesthesiol Belg; 1989; 40(2):127-9. PubMed ID: 2572138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [EEG analysis of the effectiveness of the benzodiazepine antagonist RO 15-1788 after diazepam sedation].
    Amaki Y; Horiguchi T; Takinami M; Kobayashi K
    Masui; 1990 Sep; 39(9):1114-9. PubMed ID: 2246800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled sedation in ventilated intensive care patients.
    Ritz R; Elsasser S; Schwander J
    Resuscitation; 1988; 16 Suppl():S83-9. PubMed ID: 2904688
    [No Abstract]   [Full Text] [Related]  

  • 15. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How do diazepam and flumazenil influence respiratory control by the activities of both hypoglossal and phrenic nerves in rabbits?].
    Hayashi T; Nakamura S; Ohno R; Kusumoto G; Terayama K; Murakami Y; Suzuki M; Nagasaka H; Miyata Y; Matsumoto I
    Masui; 2003 Dec; 52(12):1286-92. PubMed ID: 14733078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of diazepam serum half life and reversal of coma by activated charcoal in a patient with severe liver disease.
    Traeger SM; Haug MT
    J Toxicol Clin Toxicol; 1986; 24(4):329-37. PubMed ID: 3746988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anticonvulsant effect of the benzodiazepine antagonist, Ro 15-1788: an EEG study in 4 cases.
    Scollo-Lavizzari G
    Eur Neurol; 1984; 23(1):1-6. PubMed ID: 6425066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favourable prognosis of prolonged coma associated with large doses of diazepam in severe tetanus.
    Odusote KA; George BO; Femi-Pearse D
    Trop Geogr Med; 1976 Sep; 28(3):194-8. PubMed ID: 1006786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepine antagonist (RO 15-1788) in ethanol intoxication: a pilot study.
    Scollo-Lavizzari G; Matthis H
    Eur Neurol; 1985; 24(5):352-4. PubMed ID: 3932075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.